Liquid Biopsies: As an Emerging Tool in Cancer Diagnosis and Monitoring Therapies in Metastasis

Journal Title: Diseases & Research - Year 2023, Vol 3, Issue 1

Abstract

Despite the availability of advanced diagnosis and treatment methods, cancer is still a leading cause of morbidity. The most readily and routinely available method for cancer diagnosis is tissue biopsy. Tissue biopsies are generally based on molecular profiling of primary tumors, which can change during the metastasis stage. Therefore, it’s unable to give sufficient information about the tumor. These problems can be overcome by liquid biopsies which is considered as fast, non-invasive, and more sensitive method for cancer diagnosis. It also has applications in early diagnosis and real-time monitoring of tumor prognosis and development. This can be achieved by molecular profiling of circulating tumor cells (CTCs), cell-free DNA (cfDNA), exosomes, microRNA (miRNA), and tumor-educated platelets (TEPs) from biological fluids which are considered as biomarkers. The expression of these biomarkers gives an entire snapshot of both the primary and metastasis stages of cancer. It is very useful to determine different stages of cancer and to modify treatment strategies based on treatment response. Therefore, it opens up an opportunity to use liquid biopsies in the area of precision medicine. This review summarizes in-depth information on liquid biopsies, cancer metastasis, various methods in liquid biopsies, biomarkers such as CTCs, cfDNA, miRNA, exosomes, TEPs, and the role of these biomarkers in monitoring therapy.

Authors and Affiliations

Omkar Khade, Sagar Nagrekar, Vivek Parab, Asmita Choubey

Keywords

Related Articles

Efficacy of Platelet-Rich Plasma Combined with Wen Shen Formula in the Treatment of Thin Endometrium-Related Infertility

Objective To explore the effectiveness of Platelet-Rich Plasma (PRP) combined with Wen Shen Formula in treating thin endometrium. Methods From January 2019 to January 2023, 90 patients with thin endometrium-related infe...

Is Preoperative Radiotherapy Necessary for Resectable Locally Advanced Squamous Cell Esophageal Carcinoma?

Based on the guidelines for esophageal and esophagogastric junction cancers, the standard of care for resectable locally advanced (cT2, N0 [high-risk lesions: lymphovascular invasion, ≥3 cm, poorly differentiated]; cT1b-...

Hepatic Paragonimiasis: A Case Report and Literature Review

Paragonimiasis is a parasitic disease caused by paragnonimus, which primarily caused infection in the lung, and ectopic infection was less common. Ectopic paragonimiasis are more likely to be misdiagnosed as malignancy o...

Bioinformatics Analysis to Screen the Key Genes and Pathways in the Formation of Early T-cell Precursor Acute Lymphoblastic Leukemia

Purpose Early T-cell precursor acute lymphoblastic leukemia (EPT-ALL) is a rare type of ALL that shows genetic characteristics of both ALL and acute myeloid leukemia (AML) but has a poorer prognosis and a higher recurren...

Human Glioma Nude Mouse Xenograft Model in situ

Backgrounds Surgery and chemotherapy are difficult because of the specific location of the glioma. The establishment of a suitable in situ model of glioma is the premise of the treatment of glioma. 8 week-old female BALB...

Download PDF file
  • EP ID EP740141
  • DOI 10.54457/DR.202301007
  • Views 51
  • Downloads 1

How To Cite

Omkar Khade, Sagar Nagrekar, Vivek Parab, Asmita Choubey (2023). Liquid Biopsies: As an Emerging Tool in Cancer Diagnosis and Monitoring Therapies in Metastasis. Diseases & Research, 3(1), -. https://europub.co.uk/articles/-A-740141